Lataa...

Cost-Effectiveness of HPV Vaccination and Cervical Cancer Screening in Women over Age 30 in the United States

BACKGROUND: Women over the age of 30 are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, recommended routinely in pre-adolescent girls, is unclear in this age group. OBJECTIVE: To assess th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kim, Jane J., Ortendahl, Jesse, Goldie, Sue J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779121/
https://ncbi.nlm.nih.gov/pubmed/19841455
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!